Gut Registry

product · release 2026-09-20

Douglas Laboratories D.L. Duo-Dophilus

Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.

Organisms, fibers and substances on this label

Printed organisms · observed

Organism list

Quantities reflect printed organism rows.

Printed name and notesNormalized organismPrinted codePrinted depositPrinted quantityFlags
Lactobacillus acidophillus (La-14)Lactobacillus acidophillusLa-14not printed2,000,000,000 CFUT2; observed; quantity printed
Lactobacillus rhamnosus (Lr-32)Lacticaseibacillus rhamnosusLr-32not printed2,000,000,000 CFUT3; observed; quantity printed

Pack, dose and cost

What the label says beyond the organisms

Pack
100 Capsule(s) · Capsule
Serving
1 Capsule(s) · 1 serving(s) a day
Days of supply
100
Potency per day
4,000,000,000 CFU
Cost per day
no observed price in this release
Printed claims
2 on the label (All Other, Structure/Function). A printed claim is not evidence and does not enter any axis.
Other ingredients
3 printed: Microcrystalline Cellulose, Gelatin, Vegetable Stearate
Label target groups
Adult (18 - 50 Years), Gluten Free
Suggested use
Suggested Usage: As a dietary supplement, adults take 1 capsule daily or as directed by your health professional.
UPC
3 10539 97969 3

Printed potency

Quantity on the label

4,000,000,000 CFU per serving across 2 of 2 printed organism rows; potency basis Potency is stated at manufacture.

Evidence behind the label

Located human trials per organism

Organism on this labelPubMed records indexed as human randomized controlled trials
inulin299
Lacticaseibacillus rhamnosus465
Lacticaseibacillus rhamnosus Lr-321
Lactobacillus acidophilus La-146

Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.

Context

Where this score sits

This formulation scores above 89.4% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.

Other products carrying the same strainShared strainGut Index ScoreObserved price
Nature's Bounty Acidophilus ProbioticLa-1489.63not observed
Puritan's Pride Probiotic AcidophilusLa-1489.63not observed
NOW Acidophilus Two BillionLa-1489.63not observed
A174.50
A286.72
GIS81.22

Axes 1–2

Traceability and studiedness

Scored from the available data. Identity: A commercial strain code is printed. Quantity disclosure: 100.0%. Potency: Potency is stated at manufacture.

Axes 3–4

Measurement and brand panel

Not a measurement product, so this axis does not apply.

No brand review panel is published in this release.

Price column

Observed price

undefined: no permitted price observation in this release

Sensitivity

Preference-dependent summary

Preference interval 0.00–20.25; rank uncertainty 3186.00–3254.00; rank class 4.

Versions

Typed label snapshot edges

Preference tool

Weights slider

The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.

—

Brand: Douglas Laboratories — every published product of this brand, its potency basis and its observed reformulations.

Elsewhere in this release

Related pages

Findings computed over the whole corpus: Potency basis census · Strain dose match · Supplier code network

Tools: Unit value calculator · DSLD product check

Citation

Cite this page

Ivitskiy, I. (2026). Douglas Laboratories D.L. Duo-Dophilus. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/d-l-duo-dophilus/

The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.

Citable atoms

Release claims

  1. Douglas Laboratories D.L. Duo-Dophilus: 2 of 2 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 274125. Window: NIH DSLD snapshot Sep 2026.

    2 / 2 observed organisms · NIH DSLD snapshot Sep 2026 · product.organisms · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  2. Douglas Laboratories D.L. Duo-Dophilus: 3 of 5 observed label snapshots state a potency basis; latest basis is at manufacture. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.

    3 / 5 observed label snapshots · NIH DSLD snapshot Sep 2026 · product.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  3. Douglas Laboratories D.L. Duo-Dophilus: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 81.22 on the 100-point scale; rank class 4 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.

    1 / 1 selected label snapshots · NIH DSLD snapshot Sep 2026 · product.gis · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  4. Douglas Laboratories D.L. Duo-Dophilus has 5 observed versions across 1 formulation groups; last recorded edge type: same product. Window: NIH DSLD snapshot Sep 2026.

    5 / 1 formulation groups · NIH DSLD snapshot Sep 2026 · product.versions · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
  5. Douglas Laboratories D.L. Duo-Dophilus: 0 of 5 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.

    0 / 5 observed label versions · NIH DSLD snapshot Sep 2026 · product.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

Back to the release hub